Boundless Bio Net Profit Margin 1970-1969 | BOLD

Boundless Bio net profit margin from 1970 to 1969. Net profit margin can be defined as net Income as a portion of total sales revenue.
Boundless Bio Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Boundless Bio Inc. is a clinical stage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers. Boundless Bio Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Neo-Concepts (NCI) $0.026B 0.00
MF (MFI) $0.000B 0.00
Marex Group (MRX) $0.000B 0.00
Loar Holdings (LOAR) $0.000B 0.00
Rubrik (RBRK) $0.000B 0.00
YY (YYGH) $0.000B 0.00